Latest filing published 16 Oct 2008 for AKESIS PHARMACEUTICALS, INC., €4,977.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stuart A. Fine: trading record in brief
This profile gathers the share dealings of Stuart A. Fine in Akesis Pharmaceuticals, Inc. Over a trading history stretching from 24 July 2008 to 23 September 2008, the count stands at 8 filings.
No open-market sale appears; the market trades are 8 purchases worth €119k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Half of the purchases are above €5,862 and half below.
The latest filing, published on 16 October 2008, reports an open-market purchase of €4,977 in Akesis Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stuart A. Fine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.78Common StockSEC:0001209191-08-056584:0Canonical exit: 22 Oct 2008 (T+90)
- 2,500 shares@ US$0.80Common StockSEC:0001209191-08-056584:1Canonical exit: 22 Oct 2008 (T+90)
- 11,250 shares@ US$0.94Common StockSEC:0001209191-08-056584:2Canonical exit: 22 Oct 2008 (T+90)
- 110,050 shares@ US$0.95Common StockSEC:0001209191-08-056584:3Canonical exit: 26 Oct 2008 (T+90)
- 2,500 shares@ US$0.80Common StockSEC:0001209191-08-056584:4Canonical exit: 30 Oct 2008 (T+90)
- 19,000 shares@ US$0.85Common StockSEC:0001209191-08-056584:5Canonical exit: 30 Oct 2008 (T+90)
- 42,101 shares@ US$0.93Common StockSEC:0001209191-08-056584:6Canonical exit: 30 Oct 2008 (T+90)
- 5,000 shares@ US$0.49Common StockSEC:0001209191-08-056584:7Canonical exit: 22 Dec 2008 (T+90)
8 of 8 declarations